Jeeva Gladys, R (2013) A Study on Suzhi Kanam. Masters thesis, Government Siddha Medical College, Palayamkottai.
|
Text
320401413jeeva_gladys.pdf Download (5MB) | Preview |
Abstract
The Aim of this dissertation subject is to assess the efficacy of trial drug ‘Kanai Kirutham’ for ‘Suzhi Kanam’ without any adverse effects. • The Etiopathogenesis and symptoms of Suzhi Kanam have been correlated with that of childhood Asthma with evidences of literature. • Clinical diagnosis and selection of cases was based on clinical features described in Balavagadam Text book and also using questionnaire. • The Medicine Chosen for Treatment and management of Suzhi Kanam was Kanai Kirutham 5 to 10 ml (according to age) internally, twice a day, before food. • The Trial drug selection is based on its siddha pharmacological action to pacify the deranged vatham, pitham and kabam and also due to its Immunomodulatory and anti-asthmatic effect of ingredients. • Fifty Children (20 In-patients and 30 Out-patients) were diagnosed with Suzhi Kanam clinically and they were observed for clinical diagnosis, laboratory diagnosis, Peak expiratory flow rate during the treatment and the results were dealt in the Proforma. • The treatment covers Administration of trial drug according to the age and also includes simple Asanas, educating the patients and their parents about childhood asthma and its management, adherence to treatment and dispel fear and misconceptions. • The documentation of observations made during the clinical study showed that the drug is clinically effective. • The Preliminary GC Analysis of aqueous extract of Kanai Kirutham showed the Presence of Phytochemicals such as Alkaloids, Saponins, Glycosides, Carbohydrates and Triterpenoids. • In Biochemical analysis the trial medicine had Ferrous iron which adds to the clinical prognosis of Suzhi kanam by Kanai kirutham. • Antimicrobial activities of Kanai kirutham showed that it inhibited the Growth of Bacterial strains against Streptococcus pneumoniae and Staphylococcus aureus. • In the Pharmacological analysis, the trial drug Kanai kirutham had significant Acute anti-inflammatory action, and also had Anti-pyretic, Anti-spasmodic, Anti-Histamine action which by the virtue of controlling the airway inflammation help to improve the Patients quality of life With these benefits Kanai Kirutham can be deemed as an effective Drug for Suzhikanam (Childhood asthma). CONCLUSION: The Global burden of Respiratory Allergies in children, increasing prevalence and its impact in reducing the quality of life in children has prompted the author to choose an efficient and nutritive drug which is believed to influence the Immune System. The treatment of suzhi kanam with kanai kirutham has showed good response with no adverse effect and ensures to be safe, effective and simple to administer. Therefore it is concluded that the trial drug “kanai kirutham” along with the modalities of Pranayama, Yogasanas and patient education will benefit the society and meet patient’s and family’s expectations of satisfactory Asthma care in children.
| Item Type: | Thesis (Masters) |
|---|---|
| Uncontrolled Keywords: | Bronchial Asthma ; Suzhi Kanam ; Kanai kirutham. |
| Subjects: | AYUSH > Kuzhanthai Maruthuvam |
| Depositing User: | Kambaraman B |
| Date Deposited: | 24 Apr 2018 15:15 |
| Last Modified: | 29 Dec 2018 16:01 |
| URI: | http://repository-tnmgrmu.ac.in/id/eprint/7278 |
Actions (login required)
 |
View Item |
